Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain by Wickham, Mark E et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Research article
Oral infection of mice with Salmonella enterica serovar 
Typhimurium causes meningitis and infection of the brain
Mark E Wickham1,4, Nat F Brown1,5, John Provias2, B Brett Finlay1 and 
Brian K Coombes*3
Address: 1Michael Smith Laboratories, University of British Columbia, Vancouver, BC., Canada, 2Department of Neuropathology, Hamilton 
Health Sciences Corporation, Hamilton, ON., Canada, 3Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, 
ON, Canada, and the Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, ON., Canada, 4Phillips Ormonde Fitzpatrick, 
Level 21, 367 Collins Street, Melbourne 3000, Australia and 5Institute for Glycomics, Griffith University-Gold Coast Campus, PMB 50, Gold Coast 
Mail Centre, Gold Coast, Queensland 9726, Australia
Email: Mark E Wickham - m_wickham@mac.com; Nat F Brown - natbrowni@hotmail.com; John Provias - provijoh@hhsc.ca; B 
Brett Finlay - bfinlay@interchange.ubc.ca; Brian K Coombes* - coombes@mcmaster.ca
* Corresponding author    
Abstract
Background: Salmonella meningitis is a rare and serious infection of the central nervous system
following acute Salmonella enterica sepsis. For this pathogen, no appropriate model has been
reported in which to examine infection kinetics and natural dissemination to the brain.
Methods: Five mouse lines including C57BL/6, Balb/c, 129S6-Slc11a1tm1Mcg, 129S1/SvImJ, B6.129-
Inpp5dtm1Rkh were used in the murine typhoid model to examine the dissemination of systemic
Salmonella enterica serovar Typhimurium following oral infection.
Results: We report data on spontaneous meningitis and brain infection following oral infection of
mice with Salmonella enterica serovar Typhimurium.
Conclusion: This model may provide a system in which dissemination of bacteria through the
central nervous system and the influence of host and bacterial genetics can be queried.
Background
Salmonella species are Gram-negative, facultative intracel-
lular bacteria that are distributed globally. Two recognized
species of Salmonella include S. enterica and S. bongori,
with S. enterica serovars Typhimurium, Typhi and Enterid-
itis causing the vast majority of human infections world-
wide. Humans are infected with S. enterica though
contaminated food and water and present with a range of
acute symptoms including gastroenteritis, fever, and
headache. Although systemic infections with S. Typhi are
uncommon in developed countries, typhoid remains a
significant public health problem in the developing world
[1]. Infections with non-typhoidal strains of Salmonella
are a global burden, with an estimated 1.4 million cases in
the United States alone [2].
Salmonella meningitis is an uncommon complication of
salmonellosis, occurring more frequently in neonates and
infants [3,4], although adult cases are reported. While
considered rare in the developed world, Salmonella is a
common cause of enterobacterial meningitis in Africa,
Brazil and Thailand [4,5]. Cases in adults of Salmonella
infection report colonization of the cerebrospinal fluid,
fatal brain abscesses caused by intracranial colonization
Published: 27 June 2007
BMC Infectious Diseases 2007, 7:65 doi:10.1186/1471-2334-7-65
Received: 4 January 2007
Accepted: 27 June 2007
This article is available from: http://www.biomedcentral.com/1471-2334/7/65
© 2007 Wickham et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2007, 7:65 http://www.biomedcentral.com/1471-2334/7/65
Page 2 of 6
(page number not for citation purposes)
of S. enterica serotype Typhimurium [6], adult Salmonella
meningitis [7] and CSF pleocytosis [7]. Mortality rates are
typically high, especially in infants where rates have been
60% [8]. Other major issues concerning Salmonella men-
ingitis is a high treatment failure rate, high relapse rate
and considerable neurological sequelae in those that sur-
vive, including mental retardation, cerebral palsy, and vis-
ual and hearing impairment [3,4,8-11]. The treatment of
such complicated cases is made more difficult by the lack
of a priori knowledge of the pathogen involved, restric-
tions in pediatric use of certain antibiotics, the sharp and
continued rise in antimicrobial resistance and the prolif-
eration of multi-drug resistant organisms in community
settings. The 1970's to early 1990's witnessed the emer-
gence of Salmonella isolates resistant to the front-line anti-
microbial chloramphenicol, as well as cotrimoxazole,
ampicillin and amoxicillin [12]. In more contemporary
medicine, multi drug-resistant Salmonella such as S. Typh-
imurium strain DT104 is a constant reminder that new
anti-infectives against novel targets are in demand. DT104
is commonly resistant to ampicillin, chloramphenicol,
florfenicol, streptomycin, spectinomycin, sulfonamides
and tetracycline [13] and infections with multi-drug
resistant  S. enterica isolates are associated with higher
mortality rates than infection with susceptible strains
[14]. This apparent link between drug resistance and viru-
lence is not well understood but deserves considerable
attention.
The mechanisms of how Salmonella gains access to the
CNS and brain are not known. Outstanding questions
include (i) how does Salmonella  disseminate from the
intestinal mucosa to the CNS? (ii) how do bacteria gain
access to the brain? (iii) what cell types are utilized for
transport to the brain and intracellular replication within
this compartment? (iv) what role does host genetics and
immune repertoire play in this process? Lack of an appro-
priate animal model has made it difficult to address these
questions. An animal model in rabbits of experimental S.
enterica serotype Enteriditis meningitis has been reported
[15], although this model involved direct inoculation of
the cerebral spinal fluid using an intracisternally placed
needle. Currently there is a dearth of reports that describe
the natural progression of salmonellosis from the intesti-
nal mucosa, though the CNS and to the brain. Here we
report that the widely used oral infection model of salmo-
nellosis fulfills the criteria of natural dissemination
though a susceptible host animal from the intestinal
mucosa to the brain. This is accompanied by meningitis
and a reproducible behavioral manifestation of intracra-
nial infection that occurs in at least five genetically distinct
mouse lines and that correlates significantly with the bac-
terial load in the brain. The development of animal mod-
els of bacterial meningitis and intracranial infections will
permit a better understanding of the mechanisms of bac-
terial dissemination, the kinetics of natural disease pro-
gression, and the influence of host genetics on this
process. Such models will also be necessary for testing
investigational antimicrobials and vaccines for therapeu-
tic value against bacterial meningitis.
Methods
Bacteria and culture conditions
Salmonella enterica serovar Typhimurium strain SL1344
[16] was used throughout this study. Bacteria were rou-
tinely cultured in LB broth and on solid LB agar plates
containing streptomycin at 50 µg ml-1. Prior to animal
infections, bacteria were cultured overnight in LB broth,
washed in a buffer containing 0.1 M HEPES (pH 8.0) and
0.9% sodium chloride, and resuspended in the same
buffer to ~107 – 109 colony forming units (cfu) per ml.
Experimental animals
Experimental animals were female mice between 8 weeks
to 12 weeks of age. Five different mouse strains were used
in these experiments and include: C57BL/6 (Jackson Lab-
oratories), Balb/c (Jackson Laboratories), 129S6-
Slc11a1tm1Mcg (formerly 129/sv Ity/Nramp-/-) [17], 129S1/
SvImJ (Jackson Laboratories), B6.129-Inpp5dtm1Rkh (for-
merly 129sv/SHIP-1-/- F1) [18]. Animals were obtained
with full health reports, were deemed to be healthy and
free of infection and were housed under specific pathogen
free conditions.
Animal infections and tissue samples
All animal experiments were conducted as approved by
the local Animal Ethics Board and pursuant to guidelines
set out by the Canadian Council on Animal Care. Animal
infections were carried out by inoculating mice per os
using a gavage needle with approximately 106 to 108 wild
type S. enterica serotype Typhimurium strain SL1344 in a
0.1 ml volume. Infected animals were examined twice
daily for signs of terminal morbidity and animals that had
become moribund or that exhibited a balance defect were
euthanised by cervical dislocation. At necropsy the brain
was removed, dissected into right and left hemispheres
with one hemisphere processed for pathology and the
other placed in 1 ml of sterile phosphate buffered saline.
This latter sample was homogenized in a tissue homoge-
nizer (Polytron, Kinematica) and the homogenate was
diluted in sterile PBS and plated on solid LB agar contain-
ing streptomycin to enumerate S. Typhimurium cfu. Bac-
terial load was expressed as cfu/organ.
Pathology scoring
For pathologic scoring, brain tissues were fixed in 2%
paraformaldehyde in routine fashion [19] and sectioned
for histologic examination. Each brain was processed in
one paraffin block and three sections were cut and stained
with hematoxylin and eosin (H/E), Gram, and naptholBMC Infectious Diseases 2007, 7:65 http://www.biomedcentral.com/1471-2334/7/65
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esterase to identify mast cells. A neuropathologist exam-
ined all brain sections blindly. The degree of inflamma-
tion was scored on a 0 to 4+ scale, 0 representing no
inflammation and 4+ representing involvement of the
entire contour of the sub-arachnoid space of the section.
Results
Observations on infected mice
Our studies on Salmonella enterica pathogenesis involve
infection of the mouse in order to examine bacterial viru-
lence factors that are essential during discrete stages of
infection. During the acute phase of infection, mice
develop overt signs of infection (hunched posture,
reduced movement, loss of body weight, piloerection).
During the course of these studies over several years, we
became interested in a proportion of mice that developed
a neurological abnormality with balance defect following
infection. These mice exhibited an exaggerated lean to one
side of the body and longitudinal spinning and rotary
motion as the most prominent manifestation of infection.
Rolling occurred in either direction (however only unidi-
rectional movement was observed for any given mouse)
ranging from intermittent rolling through to constant roll-
ing (Figure 1, and Additional file 1). Neurological deficits
were not unique to one particular strain of mouse, as we
observed this behaviour in five distinct mouse lines
including wild type C57BL/6, wild type BALB/c, 129S1/
SvImJ, 129S6-Slc11a1tm1Mcg, and B6.129-Inpp5dtm1Rkh.
Examination of bacterial load in infected mice
The observed neurological deficits following infection
lead us to speculate that an intracranial infection with Sal-
monella was taking place in affected mice. To examine the
dissemination of S. Typhimurium in mice exhibiting roll-
ing behavior, bacterial load was examined in both rolling
and non-rolling infected mice. Brains of mice exhibiting
neurological deficit had significantly higher bacterial
loads (mean, 2.66 ± 0.66 × 106 cfu/organ) than infected
mice without overt signs of neurological deficit (mean,
4.21 ± 1.72 × 103 cfu/organ) (P = 0.0002, Mann Whitney)
(Figure 1). Whereas some non-rolling mice had no detect-
able cfu in the brain (approximately 10–20% of animals),
this was never the case for infected mice that had devel-
oped neurological deficits.
Pathologic examination of mouse brains
The finding that a proportion of mice developed neuro-
logical deficits following oral infection with S. Typhimu-
rium and that these mice had a significantly greater
bacterial load in the brain compared to non-affected mice
lead us to test whether mice developed meningitis follow-
ing infection. Mouse brains that were processed for his-
topathology were randomized and coded and scored by a
neuropathologist who was blinded to the treatment his-
tory and clinical outcome of the mouse. The principal
clinical finding was the presence of patchy meningitis
confined to the sub-arachnoid space in all mice with neu-
rological deficit (see Table 1). The meningitis was com-
posed of a mixture of acute and chronic inflammatory
cells, chiefly neurophils and macrophages. In general the
meningitis was consistent with a sub-acute time frame
reflecting a process of a few days to one week in duration.
The inflammation was non-necrotizing and no granulo-
mas were present. The degree of inflammation was scored
on a 0 to 4+ scale, 0 representing no inflammation and 4+
representing involvement of the entire contour of the sub-
arachnoid space of the section (data summarized in Table
1). Some of the brains had thrombosed sub-arachnoid
vessels in areas of meningitis, however none of the cases
had any cerebral infarction or encephalitis. One of the
cases with more intense meningitis also had a ventriculitis
Rolling behavior of Salmonella infected mice Figure 1
Rolling behavior of Salmonella infected mice. (A). Still 
frames of a C57BL/6 mouse infected with Salmonella enterica 
serovar Typhimurium (plus Additional file 1) which shows 
rolling behavior as a prominent feature of intracranial infec-
tion. Rotation speeds of 1 rotation per 0.3 seconds to 1.5 
seconds were observed. Rotary motion was observed in 
either direction, though only unidirectional motion was 
observed for any given mouse. (B). Bacterial load in the 
brains of rolling and non-rolling C57BL/6 mice. Infected mice 
were sacrificed and the brain removed as described in the 
text. Brain homogenates were plated on solid LB microbio-
logical agar for enumeration of bacterial colony forming units 
(cfu). Each data point represents one animal. Shown is the 
data scatter of log-transformed cfu per organ from each ani-
mal, with the horizontal line representing the geometric 
mean (P = 0.0002, Mann Whitney).
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(Figure 2). There was no obvious correlation between
development of meningitis and bacterial load in other
systemic sites of infection including the liver and spleen.
Bacterial load in these sites is typically variable in infected
mice and ranged from ~1 × 104 to 5 × 106 cfu per organ
(data not shown) regardless of the clinical diagnosis of the
animal.
Discussion
The occurrence of meningitis caused by serovars of Salmo-
nella enterica is relatively rare in developed countries [20],
but in countries such as Africa, Thailand, and Brazil [3,5],
it is a common cause of Gram-negative bacterial meningi-
tis in infants with high mortality rates being reported. A
study of infant Salmonella meningitis in Kuala Lumpur
reported an 18% fatality rate with surviving infants expe-
riencing considerable long-term neurological dysfunction
(57%) and high relapse rates (38%) [3]. Although Salmo-
nella meningitis is a rare complication of adult salmonel-
losis, the increased incidence of Salmonella bacteremia in
HIV-infected patients [21,22], may expose such individu-
als to increased risk for more disseminated and protracted
infections. Importantly, alarming increases in multi-drug
resistance Salmonella enterica may be a harbinger for more
virulent strains of Salmonella  with increased invasive
potential.
The ability of S. Typhimurium to infect the mouse brain
was related to functional virulence loci including the type
III secretion systems encoded in chromosomal genomic
islands. In our studies over several years, infection of
C57BL/6 mice with S. Typhimurium containing muta-
tions in either of these secretion systems was never found
to produce neurological deficits (over 1000 animals, data
not shown) and mutant bacteria could not be recovered
from the brains of representative infected mice (10 ani-
mals, data not shown). Neurological deficits were not
unique to one particular strain of mouse, as we observed
this behavior in five different mouse lines including wild
type C57BL/6, wild type BALB/c, 129S1/SvImJ, 129S6-
Histopathology of infected brain sections Figure 2
Histopathology of infected brain sections. (A, B) Coro-
nal sections of brain with sub-arachnoid meningeal inflamma-
tion (arrowheads). Macrophages are the predominant 
cellular infiltrate in these fields. Thrombosed sub-arachnoid 
vessels are marked with arrows. H&E; mag, 100×. (C) Area 
of ventriculitis seen in the brain of mouse #6. H&E; mag, 
200×.
Table 1: Clinical Summary
Mouse Treatment Behaviour Clinical Features a Meningitis score Genetic background
1 uninfected non-rolling normal 0 C57BL/6
2 infected non-rolling normal 0 C57BL/6
3 infected rolling meningitis, thrombosis 1+ Balb/c
4b infected rolling meningitis 2+ C57BL/6
5 infected rolling meningitis 0.5+ Balb/c
6 infected rolling meningitis, 
thrombosis, 
ventriculitis
2+ Balb/c
7 infected rolling meningitis 1+ 129S6-Slc11a1tm1Mcg
a slides were scored with the observer blinded to mouse history
b mouse shown in Additional file 1BMC Infectious Diseases 2007, 7:65 http://www.biomedcentral.com/1471-2334/7/65
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Slc11a1tm1Mcg, and B6.129-Inpp5dtm1Rkh. Much work has
investigated the genetic factors in mice involved in resist-
ance to S. Typhimurium infection [23]. These efforts have
revealed a critical role for the Slc11a1  gene (formally
Nramp1) in early innate resistance to Salmonella infection
[17]. We note that 4 out of the 5 mouse strains used in our
work carry a non-functional mutant allele of Slc11a1
(C57BL/6, BALB/c, 129S6-Slc11a1tm1Mcg, and B6.129-
Inpp5dtm1Rkh). While we did observe neurological deficits
in a mouse line that normally resists lethal infection due
to a wild type Slc11a1 allele (129S1/SvImJ), our current
sample size does not permit detailed conclusions to be
drawn regarding the impact of Slc11a1 status on meningi-
tis development. Thus, it is possible that both bacterial
and host genetic factors are involved in infection of the
brain and the development of meningitis. Further work
using larger sample sizes and controls could address these
issues. We cannot exclude hemiparesis in mice with neu-
rological deficits and the potential involvement in this
behaviour of the vestibular system will require additional
investigation.
The ability of Salmonella to disseminate naturally to the
brain in several mouse lines allows the use of the vast
array of transgenic and knockout mouse strains to address
the host genetic factors influencing CNS dissemination
including the mode of bacterial transport from intestinal
sites to systemic sites of infection, the role of various
immune cells in the trafficking of intracellular salmonel-
lae to the CNS and brain, and the role of various immune
cell migration factors in this process. We suggest that the
mouse model of Salmonella typhoid could represent a use-
ful tool in which to investigate basic mechanisms of CNS
infiltration and brain infection following oral ingestion of
Salmonella. This model could also be exploited to examine
the efficacy of investigational medicines (vaccines, anti-
infectives) to treat invasive and protracted Salmonella
infections. Importantly, this model fills a gap in the liter-
ature to address meningitis caused by naturally dissemi-
nating salmonellae.
Conclusion
Oral infection of mice with Salmonella enterica serovar
Typhimurium might represent a useful model in which to
study the dissemination of a pathogen from the natural
route of infection to the brain. Infection of the brain is fol-
lowed by meningitis and a neurological deficit in a pro-
portion of infected animals. Because more virulent strains
of  Salmonella  are commonly associated with antibiotic
resistance, the continued global epidemic spread of multi-
drug resistant Salmonella isolates in human and animal
medicine (such as S. Typhimurium DT104) presents a
serious public health issue. Drug resistance in such iso-
lates challenges our ability to treat life-threatening cases of
salmonellosis, especially in infants and children. Oral
infection of mice with S. Typhimurium is an accessible
model in which to study the host and bacterial determi-
nants that lead to dissemination and progression of infec-
tion from the gastrointestinal tract to the brain. We
propose that this model has utility for testing new antibac-
terial chemotherapies to treat complicated, life-threaten-
ing Salmonella infections.
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